Andrew Kung
About Andrew Kung
Andrew Kung, MD PhD, is a medical co-founder and Chair of the Department of Pediatrics at Memorial Sloan Kettering, known for his pioneering work in precision genomic medicine in clinical oncology.
Chair of Pediatrics at Memorial Sloan Kettering
Andrew Kung holds the position of Chair for the Department of Pediatrics at Memorial Sloan Kettering. At Memorial Sloan Kettering, one of the world's leading cancer research and treatment centers, he oversees clinical and research activities focused on pediatric oncology. His role involves steering the department’s strategic direction and ensuring the integration of advanced treatment methodologies in pediatric care.
Medical Co-Founder
Andrew Kung serves as a Medical Co-Founder, playing a crucial role in establishing and leading initiatives in the medical and clinical research fields. His co-founder status underscores his significant contributions and leadership in bringing innovative medical solutions from concept to clinical application.
Precision Genomic Medicine Expertise
Andrew Kung is an early adopter and key opinion leader (KOL) in the domain of precision genomic medicine within clinical oncology. His expertise in this field involves leveraging genomic data to inform personalized treatment plans for cancer patients, aiming to increase the efficacy and reduce the adverse effects of treatments. His contributions have positioned him at the forefront of integrating genomic insights into clinical practices.
Research Impact and H-Index
With an h-index of 112, Andrew Kung has made substantial contributions to medical research, particularly in the field of oncology. The h-index is a metric that measures both the productivity and citation impact of a researcher’s publications. An h-index of 112 indicates his work is widely recognized and frequently cited by peers, reflecting his influence and the importance of his research.